US Bancorp’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1
| Closed | -$7 | – | 4227 |
|
|
2026
Q1 | $7 | Hold |
1
| – | – | ﹤0.01% | 4159 |
|
|
2025
Q4 | $9 | Hold |
1
| – | – | ﹤0.01% | 4025 |
|
|
2025
Q3 | $12 | Hold |
1
| – | – | ﹤0.01% | 3991 |
|
|
2025
Q2 | $5 | Hold |
1
| – | – | ﹤0.01% | 4148 |
|
|
2025
Q1 | $9 | Hold |
1
| – | – | ﹤0.01% | 4172 |
|
|
2024
Q4 | $15 | Sell |
1
-337
| -100% | -$3.13K | ﹤0.01% | 4142 |
|
|
2024
Q3 | $3.37K | Sell |
338
-64
| -16% | -$966 | ﹤0.01% | 3679 |
|
|
2024
Q2 | $8.96K | Hold |
402
| – | – | ﹤0.01% | 3351 |
|
|
2024
Q1 | $23.6K | Sell |
402
-35
| -8% | -$1.51K | ﹤0.01% | 3023 |
|
|
2023
Q4 | $9.69K | Buy |
437
+414
| +1,800% | +$6.25K | ﹤0.01% | 3323 |
|
|
2023
Q3 | $499 | Sell |
23
-3
| -12% | -$118 | ﹤0.01% | 3846 |
|
|
2023
Q2 | $1.77K | Sell |
26
-3
| -10% | -$1.24K | ﹤0.01% | 3714 |
|
|
2023
Q1 | $13.4K | Hold |
29
| – | – | ﹤0.01% | 3171 |
|
|
2022
Q4 | $11.5K | Sell |
29
-15
| -34% | -$5.75K | ﹤0.01% | 3249 |
|
|
2022
Q3 | $14K | Sell |
44
-1
| -2% | -$322 | ﹤0.01% | 3221 |
|
|
2022
Q2 | $12K | Sell |
45
-8
| -15% | -$2.04K | ﹤0.01% | 3301 |
|
|
2022
Q1 | $16K | Sell |
53
-58
| -52% | -$20.2K | ﹤0.01% | 3188 |
|
|
2021
Q4 | $40K | Sell |
111
-9
| -8% | -$2.8K | ﹤0.01% | 2764 |
|
|
2021
Q3 | $31K | Sell |
120
-6
| -5% | -$2.13K | ﹤0.01% | 2893 |
|
|
2021
Q2 | $84K | Sell |
126
-417
| -77% | -$240K | ﹤0.01% | 2415 |
|
|
2021
Q1 | $472K | Buy |
543
+65
| +14% | +$69.2K | ﹤0.01% | 1533 |
|
|
2020
Q4 | $443K | Sell |
478
-69
| -13% | -$72.5K | ﹤0.01% | 1500 |
|
|
2020
Q3 | $562K | Buy |
547
+345
| +171% | +$371K | ﹤0.01% | 1265 |
|
|
2020
Q2 | $205K | Buy |
202
+20
| +11% | +$18.6K | ﹤0.01% | 1746 |
|
|
2020
Q1 | $158K | Buy |
182
+181
| +18,100% | +$180K | ﹤0.01% | 1780 |
|
|
2019
Q4 | $1K | Sell |
1
-86
| -99% | -$87.8K | ﹤0.01% | 3563 |
|
|
2019
Q3 | $81K | Hold |
87
| – | – | ﹤0.01% | 2256 |
|
|
2019
Q2 | $98K | Buy |
87
+39
| +81% | +$42.7K | ﹤0.01% | 2218 |
|
|
2019
Q1 | $65K | Buy |
48
+38
| +380% | +$51.5K | ﹤0.01% | 2378 |
|
|
2018
Q4 | $12K | Sell |
10
-9
| -47% | -$10.1K | ﹤0.01% | 2969 |
|
|
2018
Q3 | $29K | Buy |
19
+1
| +6% | +$1.54K | ﹤0.01% | 2795 |
|
|
2018
Q2 | $28K | Sell |
18
-11
| -38% | -$14.3K | ﹤0.01% | 2818 |
|
|
2018
Q1 | $34K | Buy |
29
+4
| +16% | +$5.27K | ﹤0.01% | 2766 |
|
|
2017
Q4 | $30K | Buy |
25
+8
| +47% | +$10K | ﹤0.01% | 2793 |
|
|
2017
Q3 | $23K | Buy |
17
+14
| +467% | +$14.8K | ﹤0.01% | 2837 |
|
|
2017
Q2 | $3K | Buy |
3
+2
| +200% | +$1.39K | ﹤0.01% | 3315 |
|
|
2017
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 3461 |
|
|
2016
Q4 | $0 | Buy |
+1
| New | +$499 | ﹤0.01% | 3571 |
|
Other funds holding KYNB
AC
BC
US Bancorp's KYNB Position: Q2 2026 in Review
US Bancorp sold out of Kyntra Bio (KYNB) in Q2 2026, closing a stake of 1 share — an estimated $7 sold.
US Bancorp first reported a position in KYNB in Q4 2016 and held it in 38 quarters. The position peaked at $562K in Q3 2020. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.
- US Bancorp reported no remaining Kyntra Bio position as of Q2 2026 after selling out during the quarter.
- US Bancorp sold 1 Kyntra Bio share in Q2 2026, an estimated $7.
- US Bancorp first reported a position in Kyntra Bio in Q4 2016 and held it in 38 quarters.
- US Bancorp's Kyntra Bio position peaked at $562K in Q3 2020.
- 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.